Market Overview:
The global bulk drug market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bulk drugs from hospitals, clinics, and other end-users. Additionally, the growing awareness about the benefits of using bulk drugs is also contributing to the growth of this market. On the basis of type, antibiotics accounted for a major share of the global bulk drug market in 2017. This segment is expected to grow at a CAGR of 7% during the forecast period from 2018 to 2030. The high growth rate in this segment can be attributed to factors such as rising incidence rates of infectious diseases and increasing demand for antibiotics globally. On the basis of application, hospitals accounted for a major share ofthe global bulk drug market in 2017.
Product Definition:
A bulk drug is a pharmaceutical agent that is produced in large quantities and used in the preparation of drugs in solid or semi-solid form. The importance of bulk drugs lies in their role as starting materials for the manufacture of finished dosage forms, such as tablets, capsules and injections. Bulk drugs are also used to produce active pharmaceutical ingredients (APIs), which are then sold to drug manufacturers.
Antibiotics:
Antibiotics are drugs used to treat bacterial infections. Bacterial infection includes diseases like pneumonia, ear infection, skin infections and sexually transmitted diseases. Antibiotics can be administered in two ways; as a prescription drug or as an over the counter (OTC) product. As OTC products are available without a prescription they have witnessed widespread usage resulting in its growth factor being identified as one of the key drivers for this market space.
Sulpha Drugs:
Sulpha drugs are used to treat bacterial infections. They work by damaging the cell wall of the bacteria, which makes them susceptible to immune system response. The drug is also used in treating viral infections like HIV and hepatitis B & C and some types of cancer (HIV-1 infection).
Sulpha drugs were one of the first antibiotics developed; however, they have been replaced by newer antibiotics with better safety profiles.
Application Insights:
The others segment dominated the global market and accounted for more than 35.0% share of the overall revenue in 2017. The segment includes sedatives, anthelmintics, anticonvulsants, antidepressants, anxiolytics (anti-anxiety drugs), antipsychotics and other drugs used for mental disorders. Increasing incidences of mental disorders such as anxiety and depression are anticipated to drive the demand for anxiolytics/antipsychotics over the forecast period.
On basis of application type, the global market is bifurcated into hospitals & clinics and others; Hospitals & clinics were dominant in terms of volume as well as revenue in 2017 due to increasing healthcare expenditure globally coupled with growing awareness about diseases prevention among individuals living across various developing countries worldwide including India China Brazil Indonesia etc.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to rising healthcare expenditure and increasing patient awareness regarding Bulk Drugs. Moreover, factors such as growing population, rising prevalence of chronic diseases, and high demand for generic drugs are anticipated to drive the regional market during the forecast period.
The Asia Pacific bulk drug industry is characterized by key players from China dominating revenue generation through exports mainly to North America and Europe followed by India on account of cheaper labor costs in these regions coupled with favorable government regulations pertaining to FDI investments along with other economic benefits offered under various trade agreements between Asian countries & U.S., Canada & European Union (EU).
Growth Factors:
- Increasing demand for generics and biosimilars
- Rising prevalence of chronic diseases
- Growing number of generic drug approvals by the FDA
- Proliferation of off-patent drugs
- Expansion in emerging markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Bulk Drug Market Research Report
By Type
Antibiotics, Sulpha Drugs, Vitamins,, Steroids, Analgesics, Others
By Application
Hospitals, Clinics, Others
By Companies
Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Bulk Drug Market Report Segments:
The global Bulk Drug market is segmented on the basis of:
Types
Antibiotics, Sulpha Drugs, Vitamins,, Steroids, Analgesics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Novartis
- Pfizer
- Johnson & Johnson
- Mylan
- North China Pharmaceutical Group
- Dr. Reddy’s Laboratories
- Roche
- Aurobindo pharma
- Sun Pharmaceutical Industries
- Boehringer Ingelheim GmbH
- Bayer
- BASF
- DSM
- Zhejiang Medicine
- Biocon
- Johnson Matthey
- Hisun Pharmacy
- Cambrex
- Shandong Xinhua Pharmaceutical
- Lonza group
- Huahai Pharmaceutical
- Haerbin Pharmaceutical Group
Highlights of The Bulk Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Sulpha Drugs
- Vitamins,
- Steroids
- Analgesics
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bulk Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bulk drug is a generic term for any medication that is not a brand name. Bulk drugs are usually cheaper than brand-name medications, but they may not be as effective.
Some of the key players operating in the bulk drug market are Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group.
The bulk drug market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bulk Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bulk Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bulk Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bulk Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bulk Drug Market Size & Forecast, 2020-2028
4.5.1 Bulk Drug Market Size and Y-o-Y Growth
4.5.2 Bulk Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Sulpha Drugs
5.2.3 Vitamins
5.2.4
5.2.5 Steroids
5.2.6 Analgesics
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bulk Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bulk Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Sulpha Drugs
9.6.3 Vitamins
9.6.4
9.6.5 Steroids
9.6.6 Analgesics
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Sulpha Drugs
10.6.3 Vitamins
10.6.4
10.6.5 Steroids
10.6.6 Analgesics
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Sulpha Drugs
11.6.3 Vitamins
11.6.4
11.6.5 Steroids
11.6.6 Analgesics
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Sulpha Drugs
12.6.3 Vitamins
12.6.4
12.6.5 Steroids
12.6.6 Analgesics
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Sulpha Drugs
13.6.3 Vitamins
13.6.4
13.6.5 Steroids
13.6.6 Analgesics
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bulk Drug Market: Competitive Dashboard
14.2 Global Bulk Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Novartis
14.3.3 Pfizer
14.3.4 Johnson & Johnson
14.3.5 Mylan
14.3.6 North China Pharmaceutical Group
14.3.7 Dr. Reddy’s Laboratories
14.3.8 Roche
14.3.9 Aurobindo pharma
14.3.10 Sun Pharmaceutical Industries
14.3.11 Boehringer Ingelheim GmbH
14.3.12 Bayer
14.3.13 BASF
14.3.14 DSM
14.3.15 Zhejiang Medicine
14.3.16 Biocon
14.3.17 Johnson Matthey
14.3.18 Hisun Pharmacy
14.3.19 Cambrex
14.3.20 Shandong Xinhua Pharmaceutical
14.3.21 Lonza group
14.3.22 Huahai Pharmaceutical
14.3.23 Haerbin Pharmaceutical Group
